|
|
|
Volumn 56, Issue 1440, 2014, Pages 30-31
|
|
Anoro Ellipta: An inhaled umeclidinium/vilanterol combination for COPD
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACLIDINIUM BROMIDE;
ARFORMOTEROL;
BUDESONIDE PLUS FORMOTEROL;
CYP3A4 INHIBITOR;
CYTOCHROME P450 3A4;
CYTOCHROME P450 INHIBITOR;
FLUTICASONE FUROATE PLUS VILANTEROL;
FLUTICASONE PROPIONATE PLUS SALMETEROL;
FORMOTEROL;
FORMOTEROL FUMARATE;
GLYCOPROTEIN P INHIBITOR;
INDACATEROL;
MULTIDRUG RESISTANCE PROTEIN;
PLACEBO;
SALMETEROL;
SALMETEROL XINAFOATE;
TIOTROPIUM BROMIDE;
UMECLIDINIUM PLUS VILANTEROL;
UNCLASSIFIED DRUG;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
DRUG INDUCED DISEASE;
FORCED EXPIRATORY VOLUME;
HUMAN;
LETTER;
MAINTENANCE THERAPY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ADMINISTRATION, INHALATION;
ANIMALS;
BENZYL ALCOHOLS;
CHLOROBENZENES;
CHOLINERGIC ANTAGONISTS;
DRUG COMBINATIONS;
HUMANS;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
QUINUCLIDINES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
|
|
EID: 84898453470
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (5)
|
|
References (3)
|
